Sharon Dror, Kimchi Adva, Rivolta Carlo
a Department of Ophthalmology , Hadassah-Hebrew University Medical Center , Jerusalem , Israel.
b Department of Computational Biology , Unit of Medical Genetics, University of Lausanne , Lausanne , Switzerland.
Ophthalmic Genet. 2016 Dec;37(4):366-368. doi: 10.3109/13816810.2015.1081252. Epub 2016 Feb 18.
Because of its formidable throughput, whole exome sequencing (WES) is significantly increasing the power of investigations in ophthalmic genetics. However, when applied to Mendelian conditions, WES results often contain many false positives, e.g. candidate mutations that are unrelated to the disease. For instance, highly polymorphic genes such as olfactory receptor genes carry a plethora of both common and rare alleles that are part of the normal set of variations of the human genome. Following a WES-based study, the heterozygous missense variant p.R142W in the olfactory receptor gene OR2W3 was recently reported as a pathogenic mutation causing autosomal dominant retinitis pigmentosa (RP). This variant, however, was not scored against data contained in public WES repositories, indicating that p.R142W is present in ~1 in 6500 control individuals. Therefore, if it really was pathogenic, it would be responsible for a percentage of dominant RP cases corresponding to the double of those recorded so far worldwide, or 2/3 of all RP cases (dominant, recessive, and X-linked). We therefore conclude that this sequence variant, and hence the OR2W3 gene, do not cause RP. Prompted by these findings and based on simple principles of population genetics, we suggest that WES studies should consider DNA variants as the possible cause of dominant RP only if they are present in less than 1:100,000 individuals from the general population. In addition, we propose that DNA variants belonging to highly polymorphic genes should be carefully analyzed at the functional level before inferring their pathogenicity, in RP or other genetic diseases.
由于其强大的通量,全外显子组测序(WES)显著提高了眼科遗传学研究的能力。然而,当应用于孟德尔疾病时,WES结果往往包含许多假阳性,例如与疾病无关的候选突变。例如,嗅觉受体基因等高多态性基因携带大量常见和罕见等位基因,这些都是人类基因组正常变异集的一部分。在一项基于WES的研究之后,最近有报道称嗅觉受体基因OR2W3中的杂合错义变体p.R142W是导致常染色体显性视网膜色素变性(RP)的致病突变。然而,该变体未根据公共WES存储库中包含的数据进行评分,这表明在约6500名对照个体中就有1人存在p.R142W。因此,如果它真的是致病的,那么它将导致的显性RP病例百分比将是目前全球记录病例数的两倍,或者占所有RP病例(显性、隐性和X连锁)的2/3。因此,我们得出结论,这个序列变体以及OR2W3基因不会导致RP。基于这些发现并根据群体遗传学的简单原理,我们建议WES研究只有在普通人群中每100,000人中出现的个体少于1人时,才应将DNA变体视为显性RP的可能病因。此外,我们建议在推断属于高多态性基因的DNA变体在RP或其他遗传疾病中的致病性之前,应在功能水平上对其进行仔细分析。